Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study
Bojian Zhang(Capital Medical University), Dong Zhang(Beijing Hospital), Peicong Ge(Capital Medical University), Chuming Tao(Capital Medical University), Zhikang Zhao(Capital Medical University), Chaofan Zeng(Capital Medical University), Rong Wang(Yinchuan First People's Hospital), Qian Zhang(Brigham and Women's Hospital), Yan Zhang(Shenzhen Children's Hospital), Junsheng Li(National Clinical Research Center for Digestive Diseases), Wang Jia(Capital Medical University), Wei Sun(Capital Medical University), Zhiyao Zheng(Capital Medical University), Qiheng He(Capital Medical University), Siqi Mou(Capital Medical University), Chenglong Liu(Beijing Tian Tan Hospital)
Cited by 1
Related Papers
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132
Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease
|Journal of neurosurgery|2018|105
RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance
|Journal of neurosurgery|2016|88
Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study
|Journal of neurosurgery|2017|82
Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China
|Clinical Neurophysiology|2017|81